Levetiracetam Sandoz

Levetiracetam, the active ingredient in Levetiracetam Sandoz, is an anticonvulsant presented as an oral dosage form for oral use. It is used to manage partial‑onset seizures, myoclonic seizures, and primary generalized tonic‑clonic seizures in patients diagnosed with epilepsy.

GNH USA supplies Levetiracetam Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic medication that modulates neuronal excitability in seizure disorders. - Partial‑onset seizures: reduces the frequency and severity of focal seizures. - Myoclonic seizures: helps control sudden, brief muscle jerks. - Primary generalized tonic‑clonic seizures: decreases the occurrence of convulsive episodes affecting the whole brain.

Levetiracetam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dizziness: sensation of light‑headedness or imbalance. - Headache: mild to moderate head pain. - Irritability: increased mood swings or agitation. - Nausea: feeling of stomach upset. - Nasal congestion: blocked or runny nose.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Mood changes: depression, suicidal thoughts, or aggressive behavior. - Blood disorders: low white blood cells or platelets. - Liver dysfunction: elevated liver enzymes or jaundice. - Skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before initiating therapy, consider the following safety measures. - Renal function: adjust dose if creatinine clearance is reduced. - Pregnancy: use only if potential benefit justifies potential risk; data are limited. - Breastfeeding: assess risk versus benefit, as drug may pass into milk. - Psychiatric history: monitor for mood alterations or suicidal ideation. - Concomitant CNS depressants: may enhance sedation or dizziness. - Store at ambient temperature: keep below 25 °C, retain original packaging, protect from moisture and direct sunlight.

Levetiracetam can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenobarbital: may decrease levetiracetam exposure. - Phenytoin: may lower levetiracetam concentrations.

Moderate Interactions (Monitor Closely): - Alcohol: can increase central nervous system depression. - Sedative antihistamines: may enhance drowsiness. - Opioids: potential additive sedation or respiratory depression. - Other antiepileptics: monitor seizure control and side‑effect profile.